المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

المصدر: PLoS ONE, Vol 19, Iss 3, p e0298596 (2024)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

العلاقة: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298596&type=printableTest; https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/21563d3bc5d248d7917f16c59b0f6158Test

المؤلفون: Javier Damián, Roberto Pastor-Barriuso, Fernando José García-López, Ana Ruigómez, Pablo Martínez-Martín, Jesús de Pedro-Cuesta

المصدر: PLoS ONE, Vol 14, Iss 3, p e0197789 (2019)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/651d1840e4484638927934fab2a0adadTest

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/journal_contribution/Overview_of_the_individual_studies_included_in_the_rivaroxaban_post-authorization_safety_study_PASS_program_/25362136Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.s002Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/journal_contribution/STROBE_statement_Checklist_of_items_that_should_be_included_in_reports_of_observational_studies_Safety_profile_of_rivaroxaban_in_first-time_users_treated_for_venous_thromboembolism_in_four_European_countries_/25362133Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.s001Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/journal_contribution/Characteristics_of_the_data_sources_used_for_the_study_/25362139Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.s003Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/dataset/IRs_of_intracranial_gastrointestinal_urogenital_and_other_bleeding_leading_to_hospitalization_associated_with_first_use_of_rivaroxaban_in_subgroups_of_specific_interest_/25362148Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.t002Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/figure/IRs_per_100_person-years_of_safety_outcomes_associated_with_first_use_of_rivaroxaban_and_VKAs_for_the_treatment_and_secondary_prevention_of_VTE_/25362142Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.g001Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/dataset/General_characteristics_of_study_patients_First-time_users_of_rivaroxaban_or_VKA_for_the_treatment_and_secondary_prevention_of_VTE_/25362145Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.t001Test

المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 &# 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban, +overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018

العلاقة: https://figshare.com/articles/dataset/IRs_of_mortality_per_100_person-years_in_first-time_users_of_rivaroxaban_first_episode_of_treatment_/25362151Test

الإتاحة: https://doi.org/10.1371/journal.pone.0298596.t003Test

المؤلفون: Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M. C. Herings

المساهمون: General practice, APH - Aging & Later Life, APH - Health Behaviors & Chronic Diseases, Epidemiology and Data Science, APH - Methodology, APH - Quality of Care

المصدر: García-Rodríguez, L A, Ruigómez, A, Schink, T, Voss, A, Smits, E, Swart, K M A, Balabanova, Y, Suzart-Woischnik, K, Brobert, G & Herings, R M C 2023, ' Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation : analysis of routine clinical data from four countries ', Expert opinion on drug safety . https://doi.org/10.1080/14740338.2023.2181334Test
Expert opinion on drug safety. Taylor and Francis Ltd.

مصطلحات موضوعية: Pharmacology (medical), General Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca27dc1f96c0361f2e9c0a5ea231d0eTest
https://doi.org/10.1080/14740338.2023.2181334Test